Hospital Israelita Albert Einstein

Running trials

• Not yet recruiting

  A Study to Evaluate Treatment Patterns and Investigate Adult Patients With B-cell Lymphoma

  NCT07882576· AstraZeneca· Source

• Recruiting

  A Study of DS-3939a in Participants With Solid Tumors

  NCT07739966· Phase 1/2· Daiichi Sankyo· Source

• Recruiting

  Molecular Ovarian Cancer Assessment in LatiNoAmerican PAtients

  NCT07771400· Latin American Cooperative Oncology Group· Source

• Recruiting

  Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple Myeloma

  NCT07555938· Phase 3· Hoffmann-La Roche· Source

• Recruiting

  RO7771950 Versus Tucatinib in Combination With Trastuzumab and Capecitabine in People With Locally Advanced or Metastatic Breast Cancer That is Human Epidermal Growth Factor Receptor 2 (HER2)-Positive

  NCT07413939· Phase 2/3· Hoffmann-La Roche· Source

• Recruiting

  AI-CARE: Artificial Intelligence for Cardiovascular Analysis and Risk Evaluation

  NCT07438327· Aiatella Oy· Source

• Recruiting

  A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

  NCT07225569· Phase 2· Sanofi· Source

• Recruiting

  Neuroendocrine Carcinomas: Patient Journey And Treatment Outcomes In Latin America

  NCT07192991· Latin American Cooperative Oncology Group· Source

• Recruiting

  A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes

  NCT07088068· Phase 3· Sanofi· Source

• Not yet recruiting

  "Immunoregulation in Atherosclerosis: A Single-Cell RNA Sequencing Study"

  NCT06860295· Hospital Israelita Albert Einstein· Source

• Recruiting

  Prospective and Multicentric Cohort Study of Severe and Very Severe Chronic Obstructive Pulmonary Disease (COPD) in Brazil (SCOPe).

  NCT06724315· Hospital Israelita Albert Einstein· Source

• Recruiting

  KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis

  NCT06193889· Phase 2/3· Kyverna Therapeutics· Source

• Not yet recruiting

  Brazilian Clinical Registry of Heart Transplantation

  NCT06453148· Hospital Israelita Albert Einstein· Source

• Active, not recruiting

  Study Comparing Tarlatamab and Durvalumab Versus Durvalumab Alone in First-Line Extensive-Stage Small-Cell Lung Cancer (ES-SCLC) Following Platinum, Etoposide and Durvalumab

  NCT06211036· Phase 3· Amgen· Source

• Active, not recruiting

  A Study to Test an Oral Medicine, Belumosudil, in Combination With Corticosteroids in Participants at Least 12 Years of Age With Newly Diagnosed Chronic Graft Versus Host Disease.

  NCT06143891· Phase 3· Sanofi· Source

• Active, not recruiting

  Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis

  NCT06141486· Phase 3· Sanofi· Source

• Recruiting

  MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)

  NCT06128629· Phase 3· Intellia Therapeutics· Source

• Recruiting

  BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors

  NCT06120283· Phase 1· BeOne Medicines· Source

• Recruiting

  Clinical Trial Using CAR- T Cells for Treatment of Patients With Refractory or Relapsed CD19-positive B Lymphoid Malignancies

  NCT05705570· Phase 1· Nelson Hamerschlak· Source

• Active, not recruiting

  Platelet Sub-study of the Neomindset Trial

  NCT05767723· Phase 4· Hospital Israelita Albert Einstein· Source

• Active, not recruiting

  EVOLVE-MI: EVOLocumab Very Early After Myocardial Infarction

  NCT05284747· Phase 4· Amgen· Source

• Recruiting

  Nivolumab-ipilimumab and Chemoradiation for Cervical Cancer

  NCT05492123· Phase 2· Hospital Israelita Albert Einstein· Source

• Recruiting

  Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT

  NCT05429632· Phase 3· Priothera SAS· Source

• Active, not recruiting

  A Study Comparing Imetelstat Versus Best Available Therapy for the Treatment of Intermediate-2 or High-risk Myelofibrosis (MF) Who Have Not Responded to Janus Kinase (JAK)-Inhibitor Treatment

  NCT04576156· Phase 3· Geron Corporation· Source

• Recruiting

  Sentinel Node Biopsy in Endometrial Cancer

  NCT04073706· Phase 3· Queensland Centre for Gynaecological Cancer· Source

• Active, not recruiting

  Study to Evaluate Loncastuximab Tesirine With Rituximab Versus Immunochemotherapy in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

  NCT04384484· Phase 3· ADC Therapeutics S.A.· Source

• Active, not recruiting

  A Study to Test Radium-223 With Docetaxel in Patients With Prostate Cancer

  NCT03574571· Phase 3· Memorial Sloan Kettering Cancer Center· Source

• Active, not recruiting

  International Validation Study of Sentinel Node Biopsy in Early Cervical Cancer

  NCT03386734· Centre Hospitalier Universitaire de Besancon· Source

• Active, not recruiting

  Effects of Yoga Practice in Multiple Sclerosis Patients: a Multidimensional Approach

  NCT03198598· Hospital Israelita Albert Einstein· Source

• Recruiting

  Spontaneous Coronary Artery Dissection anaLysIs of the Brazilian Updated Registry

  NCT03398850· Hospital Israelita Albert Einstein· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Coronary artery disease2 recruiting
• Metastatic breast cancer2 recruiting
• Acute lymphoblastic leukaemia1 recruiting
• Amyloidosis1 recruiting
• Aortic aneurysm1 recruiting
• Cervical cancer1 recruiting
• Childhood cancers1 recruiting
• Chronic lymphocytic leukaemia1 recruiting
• COPD1 recruiting
• Diffuse large B-cell lymphoma1 recruiting
• Endometrial cancer1 recruiting
• Hidradenitis suppurativa1 recruiting
• Lung cancer1 recruiting
• Multiple myeloma1 recruiting
• Myasthenia gravis1 recruiting
• Ovarian cancer1 recruiting
• Type 1 diabetes1 recruiting

Closed trials

• Completed

  The ELFIE-HYPERTENSION

  NCT06242483· Hospital Israelita Albert Einstein· Source

• Completed

  Assessment of Patients Undergoing Cardiac Surgery and Admitted to the Intensive Care Unit

  NCT06154473· Hospital Israelita Albert Einstein· Source

• Terminated

  A Study to Evaluate the Pharmacokinetics and Safety of Loncastuximab Tesirine in Participants With Relapsed or Refractory Diffuse Large B-cell Lymphoma or High-grade B-cell Lymphoma With Hepatic Impairment (LOTIS-10)

  NCT05660395· Phase 1· ADC Therapeutics S.A.· Source

• Completed

  Extreme Bipolar Androgen Therapy With Darolutamide and Testosterone Cypionate in Patients With Metastatic Castration-Resistant Prostate Cancer (ExBAT Trial)

  NCT04558866· Phase 2· Latin American Cooperative Oncology Group· Source

• Completed

  Percutaneous Coronary Intervention Followed by Antiplatelet Monotherapy in the Setting of Acute Coronary Syndromes

  NCT04360720· Phase 3· Hospital Israelita Albert Einstein· Source

• Completed

  Study to Compare AMG 510 "Proposed INN Sotorasib" With Docetaxel in Non Small Cell Lung Cancer (NSCLC) (CodeBreak 200).

  NCT04303780· Phase 3· Amgen· Source

• Completed

  Stereotactic Ablative Radiotherapy With Nivolumab for Early-Stage Operable Non-Small Cell Lung Cancer

  NCT04271384· Phase 2· Hospital Israelita Albert Einstein· Source

• Completed

  Ultra-high-resolution CT vs. Conventional Angiography for Detecting Coronary Heart Disease

  NCT04272060· Johns Hopkins University· Source

• Completed

  Arm-crank Exercise Training on Cardiovascular Function of Patients With Peripheral Artery Disease

  NCT03837639· Hospital Israelita Albert Einstein· Source

• Recruiting

  Handgrip Training in Patients With Peripheral Artery Disease

  NCT03663777· University of Nove de Julho· Source

• Completed

  Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants With Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-585/KEYNOTE-585)

  NCT03221426· Phase 3· Merck Sharp & Dohme LLC· Source

• Completed

  Stem Cell Transplantation With NiCord® (Omidubicel) vs Standard UCB in Patients With Leukemia, Lymphoma, and MDS

  NCT02730299· Phase 3· Gamida Cell ltd· Source

• Completed

  Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer

  NCT02003924· Phase 3· Pfizer· Source

Conditions

Diseases this institution publishes on or runs trials for.

• Familial hypercholesterolaemia6 works · 0 trials
• Follicular lymphoma5 works · 0 trials